According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$1.32 Billion. In 2023 the company made a revenue of HK$1.52 Billion a decrease over the revenue in the year 2022 that were of HK$2.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$1.32 B | -12.77% |
2023 | HK$1.52 B | -33.37% |
2022 | HK$2.28 B | 36.97% |
2021 | HK$1.66 B | -27.25% |
2020 | HK$2.28 B | -12.26% |
2019 | HK$2.60 B | 60.38% |
2018 | HK$1.62 B | 16.99% |
2017 | HK$1.39 B | 11582.37% |
2016 | HK$11.9 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |